Skip to content
← Back to this collection

PUBLICATIONS · 24335695

Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Neuro Oncol
Publication date
2014 Mar
First author
Strother DR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Strother DR
      type
      Author
    2. name
      Lafay-Cousin L
      type
      Author
    3. name
      Boyett JM
      type
      Author
    4. name
      Burger P
      type
      Author
    5. name
      Aronin P
      type
      Author
    6. name
      Constine L
      type
      Author
    7. name
      Duffner P
      type
      Author
    8. name
      Kocak M
      type
      Author
    9. name
      Kun LE
      type
      Author
    10. name
      Horowitz ME
      type
      Author
    11. name
      Gajjar A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Strother DR
      type
      Author
    2. name
      Lafay-Cousin L
      type
      Author
    3. name
      Boyett JM
      type
      Author
    4. name
      Burger P
      type
      Author
    5. name
      Aronin P
      type
      Author
    6. name
      Constine L
      type
      Author
    7. name
      Duffner P
      type
      Author
    8. name
      Kocak M
      type
      Author
    9. name
      Kun LE
      type
      Author
    10. name
      Horowitz ME
      type
      Author
    11. name
      Gajjar A
      type
      Author
    bibliography ids
    1. nci-bib-86e3dbd3aba3e8220c1a040f
    book metadata
    content sha256
    4c5adfbfaadc76421798ebdb10f03fbf431937f5a1a18e0dbc1c2d4199eda3e3
    document type
    citation
    dois
    1. 10.1093/neuonc/not163
    electronic publication date
    display
    2013 Dec 12
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24335695
    immutable id
    pubmed:24335695@4c5adfbfaadc76421798ebdb10f03fbf431937f5a1a18e0dbc1c2d4199eda3e3
    journal
    abbreviation
    Neuro Oncol
    issn electronic
    1523-5866
    issn print
    1522-8517
    issue
    3
    name
    Neuro-oncology
    nlm unique id
    100887420
    pages
    457-65
    volume
    16
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24335695
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      ef892e99c2e099c4a32521ef7ef0a9c4e9bd964ccdd91e84f6a01b6256157dd1
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2014 Mar
      precision
      month
      year
      2014
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24335695/
      title
      Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.

      Preserved source evidence · Not medical advice